“One of the very worst uses of time and money is to do something very well that need not to be done at all.”
It’s not exactly breaking news, but let’s just get this on the table: To be the …
As provider incentives move inexorably toward risk- and value-based reimbursement, larger provider groups are implementing standardized, clinically validated treatment pathways that often include a pharmaceutical intervention.… Aventria Health Group discusses the importance of defining brand value and highlighting differentiation in terms that are clear, concise and compelling to your customers, while committing your brand to a process of evolution that keeps you ahead of competition…
This is a summary of a recent podcast in which Stacey Richter and Dave Dierk, co-presidents of Aventria, discuss critical success factors for pharma marketing strategy. You can find the podcast here: Healthcare, The Third Wave: What’s Critical For Pharma …
Stacey Richter, co-President of Aventria Health Group and Aventria’s clinical strategist Lisa Erwin discuss mutually beneficial ways to collaborate with PBMs in the evolving healthcare industry. Listen in at our affiliates at relentlesshealthvalue.com.